GlobeNewswire Inc.Jul 30, 11:46 AM ET▼ Negative
Under investigation for merger with Scancell Holdings; shareholders will own only 11.1% of combined company, suggesting potential dilution concerns
Neuphoria Therapeutics news
$3.650.00%
Close Sep 28, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Neuphoria Therapeutics
Also mentions NEUP
Articles that tag NEUP but are mainly about other companies.
BenzingaMay 15, 2:44 PM ET▼ Negative
Company is exploring strategic alternatives due to lack of product revenue, profitability, and significant accumulated deficit of $186.9 million, indicating financial distress.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology